First patients being treated with Aimmune’s PALFORZIA peanut allergy drug
Aimmune Therapeutics said that the first patients in the US are being treated with the recently FDA approved peanut allergy drug PALFORZIA [Peanut (Arachis hypogaea) Allergen Powder-dnfp]. The California-based biopharma company said that specialty pharmacies are shipping initial dosing kits of the new peanut allergy drug to allergists for in-office administration to their peanut-allergic patients […]